Cannabis and Psychosis: Targeting Potential TreatmentsBORGWARDT, Stefan.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, issn 1381-6128, 307 p.Serial Issue

Abnormal effective connectivity in the psychosis high-risk stateSCHMIDT, André; BORGWARDT, Stefan.NeuroImage (Orlando, Fla.). 2013, Vol 81, pp 119-120, issn 1053-8119, 2 p.Article

Predictive power of attenuated psychosis syndrome: Is it really low? The case of mild cognitive impairmentFUSAR-POLI, Paolo; BORGWARDT, Stefan.Schizophrenia research. 2012, Vol 135, Num 1-3, pp 192-193, issn 0920-9964, 2 p.Article

Anandamide Dysfunction in Prodromal and Established PsychosisLEWEKE, F. Markus.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 5188-5193, issn 1381-6128, 6 p.Article

Psychopharmacological Boundaries of Schizophrenia with Comorbid Cannabis Use Disorder: A Critical ReviewLAZARY, Judit.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 4890-4896, issn 1381-6128, 7 p.Article

Cannabis use and Duration of Untreated Psychosis: A Systematic Review and Meta-AnalysisBURNS, Jonathan K.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 5093-5104, issn 1381-6128, 12 p.Article

Resting State Abnormalities in Psychosis Compared to Acute Cannabinoids and Opioids Challenges: A Systematic Review of Functional Imaging StudiesDENIER, Niklaus; WALTER, Marc; BENDFELDT, Kerstin et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 5081-5092, issn 1381-6128, 12 p.Article

Effects of Cannabis Use on Human Brain Structure in Psychosis: A Systematic Review Combining In Vivo Structural Neuroimaging and Post Mortem StudiesRAPP, Charlotte; BUGRA, Hilal; RIECHER-RÖSSLER, Anita et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 5070-5080, issn 1381-6128, 11 p.Article

Consistency reasoning in lattice-based fuzzy Description LogicsBORGWARDT, Stefan; PENALOZA, Rafael.International journal of approximate reasoning. 2014, Vol 55, Num 9, pp 1917-1938, issn 0888-613X, 22 p.Article

Subjective and Physiological Effects of Oromucosal Sprays Containing Cannabinoids (Nabiximols): Potentials and Limitations for Psychosis ResearchSCHOEDEL, Kerri A; HARRISON, Sarah Jane.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 5008-5014, issn 1381-6128, 7 p.Article

Why do Psychotic Patients use Cannabis? Case SeriesKOLLIAKOU, Anna; ISMAIL, Khalida; ATAKAN, Zerrin et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 4950-4959, issn 1381-6128, 10 p.Article

Gray matters! - Mapping the transition to psychosisBORGWARDT, Stefan; MCGUIRE, Philip; FUSAR-POLI, Paolo et al.Schizophrenia research. 2011, Vol 133, Num 1-3, pp 63-67, issn 0920-9964, 5 p.Article

Antipsychotic-like Effects of Cannabidiol and Rimonabant: Systematic Review of Animal and Human StudiesROSER, Patrik; HAUSSLEITER, Ida S.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 5141-5155, issn 1381-6128, 15 p.Article

Potential Protective Effects of Cannabidiol on Neuroanatomical Alterations in Cannabis Users and Psychosis: A Critical ReviewHERMANN, Derik; SCHNEIDER, Miriam.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 4897-4905, issn 1381-6128, 9 p.Article

The Endocannabinoid System and Schizophrenia: Integration of EvidenceZAMBERLETTI, Erica; RUBINO, Tiziana; PAROLARO, Daniela et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 4980-4990, issn 1381-6128, 11 p.Article

Neurocognitive Functioning and Cannabis Use in SchizophreniaSEGEV, Aviv; LEV-RAN, Shaul.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 4999-5007, issn 1381-6128, 9 p.Article

Neurophysiological Effects of Cannabinoids: Implications for Psychosis ResearchGALLINAT, Jürgen; RENTZSCH, Johannes; ROSER, Patrik et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 4938-4949, issn 1381-6128, 12 p.Article

The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ⁹-Tetrahydrocannabinol and Cannabidiol in Rodent Models of SchizophreniaARNOLD, J. C; BOUCHER, A. A; KARL, T et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 5113-5130, issn 1381-6128, 18 p.Article

Neuroanatomical Maps of Psychosis Onset: Voxel-wise Meta-Analysis of Antipsychotic-Naive VBM StudiesFUSAR-POLI, Paolo; RADUA, Joaquim; MCGUIRE, Philip et al.Schizophrenia bulletin. 2012, Vol 38, Num 6, pp 1297-1307, issn 0586-7614, 11 p.Article

Declining transition rates to psychosis: The role of diagnostic spectra and symptom overlaps in individuals with attenuated psychosis syndromeSIMON, Andor E; UMBRICHT, Daniel; LANG, Undine E et al.Schizophrenia research. 2014, Vol 159, Num 2-3, pp 292-298, issn 0920-9964, 7 p.Article

Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studiesFUSAR-POLI, Paolo; HOWES, Oliver; BECHDOLF, Andreas et al.Journal of psychiatry & neuroscience. 2012, Vol 37, Num 3, pp 170-184, issn 1180-4882, 15 p.Article

Neurological Soft Signs in Patients with Psychosis and Cannabis Abuse: A Systematic Review and Meta-Analysis of ParadoxRUIZ-VEGUILLA, Miguel; CALLADO, Luis F; FERRIN, Maite et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 5156-5170, issn 1381-6128, 15 p.Article

Cenesthopathy in adolescence: An appraisal of diagnostic overlaps along the anxiety-hypochondriasis-psychosis spectrumSIMON, Andor E; BORGWARDT, Stefan; LANG, Undine E et al.Comprehensive psychiatry (Print). 2014, Vol 55, Num 5, pp 1122-1129, issn 0010-440X, 8 p.Article

Cannabis in the Arm: What Can we Learn from Intravenous Cannabinoid Studies?ENGLUND, Amir; STONE, James M; MORRISON, Paul D et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 4906-4914, issn 1381-6128, 9 p.Article

The Association between Cannabis Use and Earlier Age at Onset of Schizophrenia and other Psychoses: Meta-analysis of Possible Confounding FactorsMYLES, Nicholas; NEWALL, Hannah; NIELSSEN, Olav et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 32, pp 5055-5069, issn 1381-6128, 15 p.Article